These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
New Jersey
(State or other jurisdiction of incorporation or organization)
|
22-2746503
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
10420 Research Road, SE, Albuquerque, New Mexico
(Address of principal executive offices)
|
87123
(Zip Code)
|
|
|
|
|
PAGE
|
| Part I | Financial Information | ||
|
|
4
|
||
|
|
27
|
||
|
34
|
|||
|
|
34
|
||
|
|
|
|
|
| Part II | Other Information | ||
|
|
36
|
||
|
36
|
|||
|
37
|
|||
|
37
|
|||
|
37
|
|||
|
|
37
|
||
|
|
|
|
|
|
|
|
38
|
|
|
|
FINANCIAL INFORMATION
|
|
Three Months Ended
March 31,
|
Six Months Ended
March 31,
|
|||||||||||||||
|
|
2011
|
2010
|
2011
|
2010
|
||||||||||||
|
Revenue
|
$ | 47,218 | $ | 48,194 | $ | 99,325 | $ | 90,596 | ||||||||
|
Cost of revenue
|
36,638 | 32,436 | 76,065 | 65,525 | ||||||||||||
|
Gross profit
|
10,580 | 15,758 | 23,260 | 25,071 | ||||||||||||
|
Operating expenses (income):
|
||||||||||||||||
|
Selling, general, and administrative
|
9,380 | 9,023 | 17,644 | 21,250 | ||||||||||||
|
Research and development
|
7,984 | 7,596 | 15,175 | 15,109 | ||||||||||||
|
Litigation settlement
|
(2,590 | ) | - | (2,590 | ) | - | ||||||||||
|
Total operating expenses
|
14,774 | 16,619 | 30,229 | 36,359 | ||||||||||||
|
Operating loss
|
(4,194 | ) | (861 | ) | (6,969 | ) | (11,288 | ) | ||||||||
|
Other expense (income):
|
||||||||||||||||
|
Interest income
|
- | (17 | ) | - | (19 | ) | ||||||||||
|
Interest expense
|
130 | 103 | 388 | 219 | ||||||||||||
|
Foreign exchange loss (gain)
|
(749 | ) | 729 | (414 | ) | 961 | ||||||||||
|
Loss from equity method investment
|
587 | - | 587 | - | ||||||||||||
|
Change in fair value of financial instruments
|
1,038 | (322 | ) | 1,310 | 810 | |||||||||||
|
Cost of financing instruments
|
5 | 108 | 10 | 336 | ||||||||||||
|
Total other expense
|
1,011 | 601 | 1,881 | 2,307 | ||||||||||||
|
Net loss
|
$ | (5,205 | ) | $ | (1,462 | ) | $ | (8,850 | ) | $ | (13,595 | ) | ||||
|
|
||||||||||||||||
|
Foreign exchange translation adjustment
|
(414 | ) | 288 | (308 | ) | 366 | ||||||||||
|
Comprehensive loss
|
$ | (5,619 | ) | $ | (1,174 | ) | $ | (9,158 | ) | $ | (13,229 | ) | ||||
|
Per share data:
|
||||||||||||||||
|
Net loss per basic and diluted share
|
$ | (0.06 | ) | $ | (0.02 | ) | $ | (0.10 | ) | $ | (0.17 | ) | ||||
|
|
||||||||||||||||
|
Weighted-average number of basic and diluted
shares outstanding
|
87,216 | 82,459 | 86,221 | 81,758 | ||||||||||||
|
As of
March 31,
2011
|
As of
September 30,
2010
|
|||||||
|
ASSETS
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
14,338
|
|
$
|
19,944
|
||
|
Restricted cash
|
|
|
2,635
|
|
|
1,298
|
||
|
Accounts receivable, net of allowance of $3,396 and $8,399, respectively
|
|
|
38,088
|
|
|
40,125
|
||
|
Inventory
|
|
|
31,361
|
|
|
32,056
|
||
|
Prepaid expenses and other current assets
|
|
|
5,972
|
|
|
5,312
|
||
|
|
|
|
|
|
||||
|
Total current assets
|
|
|
92,394
|
|
|
98,735
|
||
|
|
|
|
|
|
||||
|
Property, plant and equipment, net
|
|
|
44,827
|
|
|
46,990
|
||
|
Goodwill
|
|
|
20,384
|
|
|
20,384
|
||
|
Other intangible assets, net
|
|
|
9,734
|
|
|
10,738
|
||
|
Other non-current assets, net of allowance of $5,254 and $0, respectively
|
|
|
3,904
|
|
|
991
|
||
|
|
|
|
|
|
||||
|
Total assets
|
|
$
|
171,243
|
|
$
|
177,838
|
||
|
LIABILITIES and SHAREHOLDERS’ EQUITY
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Borrowings from credit facility
|
|
$
|
13,710
|
|
$
|
10,573
|
||
|
Accounts payable
|
24,399
|
26,156
|
||||||
|
Warrant liability
|
1,981
|
-
|
||||||
|
Equity method investment
|
1,195
|
-
|
||||||
|
Accrued expenses and other current liabilities
|
|
|
22,206
|
|
|
27,115
|
||
|
|
|
|
|
|
||||
|
Total current liabilities
|
|
|
63,491
|
|
|
63,844
|
||
|
|
|
|
|
|
||||
|
Warrant liability
|
-
|
475
|
||||||
|
Other long-term liabilities
|
|
|
38
|
|
|
87
|
||
|
|
|
|
|
|
||||
|
Total liabilities
|
|
|
63,529
|
|
|
64,406
|
||
|
|
|
|
|
|
||||
|
Commitments and contingencies
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
Shareholders’ equity:
|
|
|
|
|
||||
|
Preferred stock, $0.0001 par, 5,882 shares authorized; no shares outstanding
|
|
|
-
|
|
|
-
|
||
|
Common stock, no par value, 200,000 shares authorized;
88,517 shares issued and 88,358 shares outstanding as of March 31, 2011;
85,346 shares issued and 85,187 shares outstanding as of September 30, 2010
|
|
|
697,415
|
|
|
701,997
|
||
|
Accumulated deficit
|
|
|
(588,087
|
)
|
|
|
(587,259
|
)
|
|
Accumulated other comprehensive income
|
|
|
469
|
|
|
777
|
||
|
Treasury stock, at cost; 159 shares as of March 31, 2011 and September 30, 2010
|
|
|
(2,083
|
)
|
|
|
(2,083
|
)
|
|
Total shareholders’ equity
|
|
|
107,714
|
|
|
113,432
|
||
|
|
|
|
|
|
||||
|
Total liabilities and shareholders’ equity
|
|
$
|
171,243
|
|
$
|
177,838
|
|
Six Months Ended
March 31,
|
||||||||
| 2011 | 2010 | |||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(8,850
|
)
|
|
$
|
(13,595
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
||||
|
Depreciation and amortization expense
|
|
|
5,970
|
|
6,236
|
|||
|
Stock-based compensation expense
|
|
|
2,024
|
|
5,250
|
|||
|
Change in fair value of financial instruments
|
1,310
|
810
|
||||||
|
Compensatory stock issuances
|
|
|
587
|
|
528
|
|||
|
Loss from equity method investment
|
587
|
-
|
||||||
|
Provision for product warranty
|
144
|
726
|
||||||
|
Provision for doubtful accounts
|
|
|
79
|
|
(410
|
)
|
||
|
Cost of financing instruments
|
-
|
322
|
||||||
|
Loss on disposal of equipment
|
-
|
89
|
||||||
|
Total non-cash adjustments
|
|
|
10,701
|
|
13,551
|
|||
|
|
|
|
|
|||||
|
Changes in operating assets and liabilities:
|
|
|
|
|||||
|
Accounts receivable
|
|
|
2,059
|
|
(3,472
|
)
|
||
|
Inventory
|
|
|
722
|
|
55
|
|||
|
Other assets
|
|
|
(3,504
|
)
|
|
236
|
||
|
Accounts payable
|
|
|
(1,766
|
)
|
|
5,333
|
||
|
Accrued expenses and other current liabilities
|
|
|
(371
|
)
|
|
(2,279
|
)
|
|
|
Total change in operating assets and liabilities
|
|
|
(2,860
|
)
|
|
(127
|
)
|
|
|
Net cash used in operating activities
|
|
|
(1,009
|
)
|
|
(171
|
)
|
|
|
|
|
|
|
|||||
|
Cash flows from investing activities:
|
|
|
|
|||||
|
Investment in unconsolidated affiliate
|
(4,000
|
)
|
-
|
|||||
|
Purchase of plant and equipment
|
|
|
(1,685
|
)
|
|
(243
|
)
|
|
|
(Increase) release of restricted cash
|
|
|
(1,338
|
)
|
|
1,096
|
||
|
Purchase of business
|
(750
|
)
|
-
|
|||||
|
Investment in patents
|
(331
|
)
|
(358
|
)
|
||||
|
Sales of available-for-sale securities
|
-
|
100
|
||||||
|
Net cash (used in) provided by investing activities
|
|
(8,104
|
)
|
595
|
||||
|
Cash flows from financing activities:
|
|
|
|
|||||
|
Net proceeds from (payments on) borrowings from credit facilities
|
3,137
|
(671
|
)
|
|||||
|
Proceeds from employee stock purchase plan
|
|
|
555
|
|
505
|
|||
|
Proceeds from exercise of employee stock options
|
|
|
248
|
|
-
|
|||
|
Proceeds related to officer and director purchase plan
|
|
|
17
|
|
-
|
|||
|
Payments on capital lease obligations
|
|
|
(3
|
)
|
|
-
|
||
|
Net proceeds from equity line of credit
|
-
|
1,980
|
||||||
|
Net payments on short-term debt
|
-
|
(114
|
)
|
|||||
|
Net cash provided by financing activities
|
|
|
3,954
|
|
1,700
|
|||
|
|
|
|
|
|||||
|
Effect of foreign currency
|
|
|
(447
|
)
|
|
1,029
|
||
|
Net (decrease) increase in cash and cash equivalents
|
|
|
(5,606
|
)
|
|
3,153
|
||
|
|
|
|
|
|||||
|
Cash and cash equivalents at beginning of period
|
|
|
19,944
|
|
14,028
|
|||
|
Cash and cash equivalents at end of period
|
|
$
|
14,338
|
$
|
17,181
|
|||
|
|
|
|
||||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
|
|
||||||
|
Cash paid during the period for interest
|
|
$
|
701
|
$
|
148
|
|||
|
Cash paid during the period for income taxes
|
|
$
|
-
|
$
|
-
|
|||
|
NON-CASH INVESTING AND FINANCING ACTIVITIES
|
||||||||
|
Issuance of common stock under equity line of credit
|
$
|
-
|
$
|
228
|
||||
|
|
-
|
the valuation of inventory, goodwill, intangible assets, warrants, and stock based compensation;
|
|
|
-
|
assessment of recovery of long-lived assets;
|
|
|
-
|
revenue recognition associated with the percentage of completion method; and,
|
|
|
-
|
the allowance for doubtful accounts and warranty accruals.
|
|
Number of
Shares
|
Weighted
Average
Exercise Price
|
Weighted Average
Remaining
Contractual Life
(in years)
|
||||||||||
|
Outstanding as of September 30, 2010
|
8,722,125
|
$
|
4.70
|
7.02
|
||||||||
|
Granted
|
724,000
|
|||||||||||
|
Exercised
|
(181,550
|
)
|
||||||||||
|
Forfeited
|
(82,326
|
)
|
||||||||||
|
Cancelled
|
(124,268
|
)
|
||||||||||
|
Outstanding as of March 31, 2011
|
9,057,981
|
$
|
4.49
|
6.81
|
||||||||
|
Exercisable as of March 31, 2011
|
4,890,612
|
$
|
5.52
|
5.71
|
||||||||
|
Vested and expected to vest as of March 31, 2011
|
6,150,249
|
$
|
4.98
|
6.23
|
| As of March 31, 2011 | |||||||||||||||||||||
|
|
Number of Stock Options Outstanding
|
Options Exercisable
|
|||||||||||||||||||
|
Exercise Price
of Stock Options
|
Number
Outstanding
|
Weighted-
Average
Remaining
Contractual
Life (years)
|
Weighted -
-Average
Exercise Price
|
Number
Exercisable
|
Weighted-
Average
Exercise
Price
|
||||||||||||||||
| $<5.00 | 4,920,783 | 7.17 | $ | 1.85 | 1,997,175 | $ | 2.61 | ||||||||||||||
|
>=$5.01 to <$10.00
|
4,106,498 | 6.38 | 7.61 | 2,873,437 | 7.49 | ||||||||||||||||
|
=>$10.00
|
30,700 | 6.30 | 11.34 | 20,000 | 11.32 | ||||||||||||||||
|
Total
|
9,057,981 | 6.81 | $ | 4.49 | 4,890,612 | $ | 5.52 | ||||||||||||||
|
Number of
Shares
|
Weighted
Average
Grant Date
Fair Value
|
|||||||
|
Non-vested as of September 30, 2010
|
-
|
$
|
-
|
|||||
|
Granted
|
1,665,900
|
1.42
|
||||||
|
Vested
|
-
|
-
|
||||||
|
Cancelled
|
(4,000
|
)
|
1.42
|
|||||
|
Non-vested as of March 31, 2011
|
1,661,900
|
$
|
1.42
|
|
Number of
Common Stock
Shares
|
Purchase Price
per Share of
Common Stock
|
|||||||
|
Amount of shares reserved for the ESPP
|
4,500,000
|
|
||||||
|
|
|
|
||||||
|
Number of shares issued for calendar years 2000 through 2008
|
(1,716,446
|
)
|
$ |
0.88 - $40.93
|
||||
|
Number of shares issued for calendar year 2009
|
(1,073,405
|
)
|
$ |
0.92
|
||||
|
Number of shares issued for calendar year 2010
|
(651,700
|
)
|
$ |
0.74
|
||||
|
Number of shares issued for calendar year 2011
|
(781,802
|
)
|
$ |
0.71
|
||||
|
|
|
|
||||||
|
Remaining shares reserved for the ESPP
|
276,647
|
|
|
(in thousands, except per share data)
|
For the Three Months
Ended March 31,
|
For the Six Months
Ended March 31,
|
||||||||||||||
|
2011
|
2010
|
2011
|
2010 | |||||||||||||
| Stock-based compensation expense by award type: |
|
|||||||||||||||
|
Employee stock options
|
$ | 1,040 | $ | 1,927 | $ | 1,722 | $ | 4,933 | ||||||||
|
Restricted stock awards
|
90 | - | 90 | - | ||||||||||||
|
Employee stock purchase plan
|
77 | 137 | 212 | 317 | ||||||||||||
|
Total stock-based compensation expense
|
$ | 1,207 | $ | 2,064 | $ | 2,024 | $ | 5,250 | ||||||||
|
|
||||||||||||||||
|
Stock-based compensation expense
by expense category:
|
||||||||||||||||
|
Cost of revenue
|
$ | 143 | $ | 387 | $ | 256 | $ | 876 | ||||||||
|
Selling, general, and administrative
|
817 | 1,386 | 1,324 | 3,676 | ||||||||||||
|
Research and development
|
247 | 291 | 444 | 698 | ||||||||||||
|
Total stock-based compensation expense
|
$ | 1,207 | $ | 2,064 | $ | 2,024 | $ | 5,250 | ||||||||
|
Net effect on net loss per basic and diluted share
|
$ | (0.01 | ) | $ | (0.03) | $ | (0.02 | ) | $ | (0.06 | ) | |||||
|
Assumptions used in Black-Scholes
Option Valuation Model
|
|
For the Three Months
Ended March 31,
|
For the Six Months
Ended March 31,
|
|||||||||||||
|
|
|
2011
|
2010
|
2011
|
2010
|
|||||||||||
|
Expected dividend yield
|
-
|
-
|
-
|
-
|
||||||||||||
|
Expected stock price volatility
|
101.0
|
%
|
97.3
|
%
|
98.6
|
%
|
97.1
|
%
|
||||||||
|
Risk-free interest rate
|
1.9
|
%
|
2.5
|
%
|
1.4
|
%
|
2.4
|
%
|
||||||||
|
Expected term (in years)
|
4.7
|
4.5
|
4.9
|
4.6
|
||||||||||||
|
Estimated pre-vesting forfeitures
|
32.5
|
%
|
32.7
|
%
|
32.5
|
%
|
32.7
|
%
|
||||||||
|
|
Number of Common Stock
Shares Available for Future Issuances
|
|||
|
For exercise of outstanding stock options
|
9,057,981
|
|||
|
For future issuances to employees under the ESPP
|
276,647
|
|||
|
For future stock option or restricted stock
awards under the 2010 Equity Incentive Plan
|
1,616,100
|
|||
|
For future exercise of warrants
|
3,000,003
|
|||
|
For future issuance under the ODPP
|
493,985
|
|||
|
Total reserved
|
14,444,716
|
|||
|
(in thousands)
|
As of
March 31,
2011
|
As of
September 30,
2010
|
||||||
|
|
||||||||
|
Accounts receivable
|
$ | 35,577 | $ | 37,574 | ||||
|
Accounts receivable – unbilled
|
5,907 | 10,950 | ||||||
|
|
||||||||
|
Accounts receivable, gross
|
41,484 | 48,524 | ||||||
|
Allowance for doubtful accounts
|
(3,396 | ) | (8,399 | ) | ||||
|
|
||||||||
|
Accounts receivable, net
|
$ | 38,088 | $ | 40,125 | ||||
|
|
-
|
The contract includes enforceable rights regarding goods or services to be provided to the customer, the consideration to be exchanged, and the manner and terms of settlement;
|
|
|
-
|
Both the Company and the customer are expected to satisfy all of the contractual obligations; and,
|
|
|
-
|
Reasonably reliable estimates of total revenue, total cost, and the progress toward completion can be made.
|
|
(in thousands)
|
Six Months Ended
March 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Balance at beginning of period
|
$ | 8,399 | $ | 7,125 | ||||
|
Expense - charge to provision, net of (recoveries)
|
79 | (410 | ) | |||||
|
Reclass of a specific allowance for doubtful accounts
to a long-term receivables account
|
(5,254 | ) | - | |||||
|
Impact from foreign exchange translation adjustment
|
181 | (200 | ) | |||||
|
Write-offs - deductions against receivables
|
(9 | ) | (1,065 | ) | ||||
|
Balance at end of period
|
$ | 3,396 | $ | 5,450 | ||||
|
(in thousands)
|
As of
March 31,
2011
|
As of
September 30,
2010
|
||||||
|
|
||||||||
|
Raw materials
|
$ | 13,703 | $ | 13,632 | ||||
|
Work in-process
|
6,529 | 6,496 | ||||||
|
Finished goods
|
11,129 | 11,928 | ||||||
|
|
||||||||
|
Inventory
|
$ | 31,361 | $ | 32,056 | ||||
|
(in thousands)
|
As of
March 31,
2011
|
As of
September 30,
2010
|
||||||
|
|
||||||||
|
Land
|
$ | 1,502 | $ | 1,502 | ||||
|
Building and improvements
|
34,910 | 34,854 | ||||||
|
Equipment
|
103,389 | 101,310 | ||||||
|
Furniture and fixtures
|
3,065 | 3,065 | ||||||
|
Computer hardware and software
|
3,647 | 3,616 | ||||||
|
Leasehold improvements
|
832 | 854 | ||||||
|
Construction in progress
|
1,334 | 992 | ||||||
|
|
||||||||
|
Property, plant, and equipment, gross
|
148,679 | 146,193 | ||||||
|
Accumulated depreciation
|
(103,852 | ) | (99,203 | ) | ||||
|
|
||||||||
|
Property, plant, and equipment, net
|
$ | 44,827 | $ | 46,990 | ||||
|
(in thousands)
|
As of March 31, 2011
|
As of September 30, 2010
|
||||||||||||||||||||||
|
|
Gross
Assets
|
Accumulated
Amortization
|
Net
Assets
|
Gross Assets
|
Accumulated
Amortization
|
Net
Assets
|
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Fiber Optics:
|
||||||||||||||||||||||||
|
Core Technology
|
$ | 15,555 | $ | (10,094 | ) | $ | 5,461 | $ | 15,555 | $ | (9,275 | ) | $ | 6,280 | ||||||||||
|
Customer Relations
|
4,381 | (1,858 | ) | 2,523 | 4,381 | (1,644 | ) | 2,737 | ||||||||||||||||
|
Patents
|
4,821 | (4,144 | ) | 677 | 4,725 | (4,021 | ) | 704 | ||||||||||||||||
| 24,757 | (16,096 | ) | 8,661 | 24,661 | (14,940 | ) | 9,721 | |||||||||||||||||
|
Photovoltaics:
|
||||||||||||||||||||||||
|
Patents
|
2,177 | (1,104 | ) | 1,073 | 1,941 | (924 | ) | 1,017 | ||||||||||||||||
|
|
||||||||||||||||||||||||
|
Total
|
$ | 26,934 | $ | (17,200 | ) | $ | 9,734 | $ | 26,602 | $ | (15,864 | ) | $ | 10,738 | ||||||||||
|
(in thousands)
|
|
Estimated Future
Amortization
Expense
|
||
|
Six months ended September 30, 2011
|
$
|
1,281
|
||
|
Fiscal year ended September 30, 2012
|
2,304
|
|||
|
Fiscal year ended September 30, 2013
|
1,968
|
|||
|
Fiscal year ended September 30, 2014
|
1,433
|
|||
|
Fiscal year ended September 30, 2015
|
1,008
|
|||
|
Thereafter
|
1,740
|
|||
|
|
||||
|
Total future amortization expense
|
$
|
9,734
|
||
|
(in thousands)
|
As of
March 31,
2011
|
As of
September 30,
2010
|
||||||
|
|
||||||||
|
Compensation-related
|
$ | 4,880 | $ | 4,001 | ||||
|
Warranty
|
4,683 | 4,851 | ||||||
|
Advanced payments
|
3,996 | 7,437 | ||||||
|
Tangshan termination fee
|
2,775 | 2,775 | ||||||
|
Royalty
|
1,706 | 1,772 | ||||||
|
Income and other taxes
|
895 | 747 | ||||||
|
Self insurance
|
878 | 957 | ||||||
|
Professional fees
|
647 | 2,530 | ||||||
|
Restructuring accrual
|
583 | 780 | ||||||
|
Loss on sale commitments
|
449 | 561 | ||||||
|
Loss on purchase commitments
|
192 | 86 | ||||||
|
Other
|
522 | 618 | ||||||
|
|
||||||||
|
Accrued expenses and other current liabilities
|
$ | 22,206 | $ | 27,115 | ||||
|
(in thousands)
|
Six Months Ended
March 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Balance at beginning of period
|
$ | 4,851 | $ | 4,287 | ||||
|
Expense - charge to provision
|
144 | 726 | ||||||
|
Utilization of warranty accrual
|
(312 | ) | (351 | ) | ||||
|
|
||||||||
|
Balance at end of period
|
$ | 4,683 | $ | 4,662 | ||||
|
Severance-
related
accruals
|
Restructuring-
related
accruals
|
Total
|
||||||||||
|
Balance as of September 30, 2010
|
$ | 180 | $ | 600 | $ | 780 | ||||||
|
Expense - charge to accrual
|
20 | - | 20 | |||||||||
|
Payments on accrual
|
(118 | ) | (99 | ) | (217 | ) | ||||||
|
Balance as of March 31, 2011
|
$ | 82 | $ | 501 | $ | 583 | ||||||
|
(in thousands)
|
|
Estimated Future
Minimum Lease
Payments
|
||
|
Six months ended September 30, 2011
|
$
|
985
|
||
|
Fiscal year ended September 30, 2012
|
1,238
|
|||
|
Fiscal year ended September 30, 2013
|
892
|
|||
|
Fiscal year ended September 30, 2014
|
182
|
|||
|
Fiscal year ended September 30, 2015
|
182
|
|||
|
Thereafter
|
2,670
|
|||
|
|
||||
|
Total minimum lease payments
|
$
|
6,149
|
||
|
Segment Revenue
(in thousands)
|
For the Three Months
Ended March 31,
|
|||||||||||||||
|
2011
|
2010
|
|||||||||||||||
|
Revenue
|
% of Revenue
|
Revenue
|
% of Revenue
|
|||||||||||||
|
Fiber Optics
|
$ | 30,032 | 64 | % | $ | 30,204 | 63 | % | ||||||||
|
Photovoltaics
|
17,186 | 36 | 17,990 | 37 | ||||||||||||
|
Total revenue
|
$ | 47,218 | 100 | % | $ | 48,194 | 100 | % | ||||||||
|
Segment Revenue
(in thousands)
|
For the Six Months
Ended March 31,
|
|||||||||||||||
|
2011
|
2010
|
|||||||||||||||
|
Revenue
|
% of Revenue
|
Revenue
|
% of Revenue
|
|||||||||||||
|
Fiber Optics
|
$ | 61,484 | 62 | % | $ | 55,812 | 62 | % | ||||||||
|
Photovoltaics
|
37,841 | 38 | 34,784 | 38 | ||||||||||||
|
Total revenue
|
$ | 99,325 | 100 | % | $ | 90,596 | 100 | % | ||||||||
|
Geographic Revenue
(in thousands)
|
For the Three Months
Ended March 31,
|
|||||||||||||||
|
2011
|
2010
|
|||||||||||||||
|
|
Revenue
|
% of Revenue
|
Revenue
|
% of Revenue
|
||||||||||||
|
North America
|
$ | 34,955 | 74 | % | $ | 32,135 | 67 | % | ||||||||
|
Far East Asia
|
9,669 | 21 | 11,714 | 24 | ||||||||||||
|
Europe
|
2,115 | 4 | 3,977 | 8 | ||||||||||||
|
Other
|
479 | 1 | 368 | 1 | ||||||||||||
|
Total revenue
|
$ | 47,218 | 100 | % | $ | 48,194 | 100 | % | ||||||||
|
Geographic Revenue
(in thousands)
|
For the Six Months
Ended March 31,
|
|||||||||||||||
|
2011
|
2010
|
|||||||||||||||
|
|
Revenue
|
% of Revenue
|
Revenue
|
% of Revenue
|
||||||||||||
|
North America
|
$ | 70,171 | 70 | % | $ | 66,496 | 73 | % | ||||||||
|
Far East Asia
|
23,898 | 24 | 17,984 | 16 | ||||||||||||
|
Europe
|
4,606 | 5 | 5,254 | 6 | ||||||||||||
|
Other
|
650 | 1 | 862 | 5 | ||||||||||||
|
Total revenue
|
$ | 99,325 | 100 | % | $ | 90,596 | 100 | % | ||||||||
|
Significant Customers
As a percentage of total consolidated revenue
|
For the Three Months
Ended March 31,
|
For the Six Months
Ended March 31,
|
|||||||||||
|
|
2011
|
2010
|
2011
|
2010
|
|||||||||
|
Fiber Optics – related customers:
|
|||||||||||||
|
Cisco Systems, Inc.
|
-
|
14
|
%
|
-
|
|
|
14
|
%
|
|||||
|
Motorola
|
-
|
10
|
%
|
-
|
|
|
-
|
||||||
|
Photovoltaics – related customer:
|
|||||||||||||
|
Loral Space & Communications
|
13
|
%
|
-
|
13
|
%
|
|
10
|
%
|
|||||
|
Statement of Operations Data
(in thousands)
|
|
For the Three Months
Ended March 31,
|
For the Six Months
Ended March 31,
|
|
||||||||||||
|
|
|
2011 | 2010 | 2011 | 2010 |
|
||||||||||
|
Operating (loss) income:
|
||||||||||||||||
|
Fiber Optics segment
|
$
|
(5,106
|
)
|
$
|
(3,691
|
)
|
$
|
(9,696
|
)
|
$
|
(10,680
|
)
|
||||
|
Photovoltaics segment
|
912
|
2,830
|
2,727
|
(608
|
)
|
|||||||||||
|
Operating loss
|
$
|
(4,194
|
)
|
$
|
(861
|
)
|
$
|
(6,969
|
)
|
$
|
(11,288
|
)
|
||||
|
Segment Depreciation and Amortization
(in thousands)
|
For the Three Months
Ended March 31,
|
For the Six Months
Ended March 31,
|
||||||||||||||
|
|
2011
|
2010
|
2011
|
2010
|
||||||||||||
|
Fiber Optics segment
|
$ | 1,630 | $ | 1,787 | $ | 3,278 | $ | 3,551 | ||||||||
|
Photovoltaics segment
|
1,333 | 1,331 | 2,692 | 2,685 | ||||||||||||
|
Depreciation and amortization
|
$ | 2,963 | $ | 3,118 | $ | 5,970 | $ | 6,236 | ||||||||
|
Long-lived Assets
(in thousands)
|
As of
March 31,
2011
|
As of
September 30,
2010
|
||||||
|
Fiber Optics segment
|
$ | 29,360 | $ | 31,175 | ||||
|
Photovoltaics segment
|
44,587 | 45,935 | ||||||
|
Corporate division
|
998 | 1,002 | ||||||
|
Long-lived assets
|
$ | 74,945 | $ | 78,112 | ||||
|
|
-
|
Level 1 inputs are unadjusted quoted prices in active markets for identical assets or liabilities. The Company classifies investments within Level 1 if quoted prices are available in active markets. Level 1 assets include instruments valued based on quoted market prices in active markets which generally could include money market funds, corporate publicly traded equity securities on major exchanges and U.S. Treasury notes with quoted prices on active markets.
|
|
|
-
|
Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. The Company classifies items in Level 2 if the investments are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. These investments could include: government agencies, corporate bonds, commercial paper, and auction rate securities.
|
|
|
-
|
Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The Company did not hold financial assets or liabilities within Level 3.
|
|
(in thousands)
|
As of March 31, 2011
|
|||||||||||||||
|
Quoted Prices in
Active Markets
for Identical Assets
[Level 1]
|
Significant
Other
Observable
Remaining
Inputs
[Level 2]
|
Significant
Unobservable
Inputs
[Level 3]
|
Total
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Money market fund deposits
|
$ | 14,338 | $ | - | $ | - | $ | 14,338 | ||||||||
|
Restricted fund deposits
|
2,635 | - | - | 2,635 | ||||||||||||
|
Total assets measured at fair value
|
$ | 16,973 | $ | - | $ | - | $ | 16,973 | ||||||||
|
Liabilities
|
||||||||||||||||
|
Warrants
|
$ | - | $ | 1,981 | $ | - | $ | 1,981 | ||||||||
|
(in thousands)
|
As of September 30, 2010
|
|||||||||||||||
|
Quoted Prices in
Active Markets
for Identical Assets
[Level 1]
|
Significant
Other
Observable
Remaining
Inputs
[Level 2]
|
Significant
Unobservable
Inputs
[Level 3]
|
Total
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Money market fund deposits
|
$ | 19,944 | $ | - | $ | - | $ | 19,944 | ||||||||
|
Restricted fund deposits
|
1,298 | - | - | 1,298 | ||||||||||||
|
Total assets measured at fair value
|
$ | 21,242 | $ | - | $ | - | $ | 21,242 | ||||||||
|
Liabilities
|
||||||||||||||||
|
Warrants
|
$ | - | $ | 475 | $ | - | $ | 475 | ||||||||
|
Assumptions used in the
Monte Carlo Option
Pricing Model
|
2008 Warrants
|
2009 Warrants
|
||||||||||||||
|
|
As of
March 31,
2011
|
As of
September 30,
2010
|
As of
March 31,
2011
|
As of
September 30,
2010
|
||||||||||||
|
Expected dividend yield
|
-
|
-
|
|
-
|
|
|
-
|
|||||||||
|
Expected stock price volatility
|
86
|
.0%
|
117
|
.9%
|
106
|
.5%
|
100
|
.0%
|
||||||||
|
Risk-free interest rate
|
0
|
.8%
|
0
|
.4%
|
2
|
.6%
|
1
|
.3%
|
||||||||
|
Expected term (in years)
|
1
|
.89
|
2
|
.39
|
|
4
|
.00
|
|
|
4
|
.50
|
|
||||
|
Three Months Ended
March 31,
|
Six Months Ended
March 31,
|
|||||||||||||||
|
|
2011
|
2010
|
2011
|
2010
|
||||||||||||
|
Revenue
|
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
|
Cost of revenue
|
77.6 | 67.3 | 76.6 | 72.3 | ||||||||||||
|
Gross profit
|
22.4 | 32.7 | 23.4 | 27.7 | ||||||||||||
|
Operating expenses (income):
|
||||||||||||||||
|
Selling, general, and administrative
|
19.9 | 18.7 | 17.7 | 23.5 | ||||||||||||
|
Research and development
|
16.9 | 15.8 | 15.3 | 16.7 | ||||||||||||
|
Litigation settlement
|
(5.5 | ) | - | (2.6 | ) | - | ||||||||||
|
Total operating expenses
|
31.3 | 34.5 | 30.4 | 40.2 | ||||||||||||
|
Operating loss
|
(8.9 | ) | (1.8 | ) | (7.0 | ) | (12.5 | ) | ||||||||
|
Other expense (income):
|
||||||||||||||||
|
Interest income
|
- | - | - | - | ||||||||||||
|
Interest expense
|
0.3 | 0.2 | 0.4 | 0.2 | ||||||||||||
|
Foreign exchange loss (gain)
|
(1.6 | ) | 1.5 | (0.4 | ) | 1.0 | ||||||||||
|
Loss from equity method investment
|
1.2 | - | 0.6 | - | ||||||||||||
|
Change in fair value of financial instruments
|
2.2 | (0.7 | ) | 1.3 | 0.9 | |||||||||||
|
Cost of financing instruments
|
- | 0.2 | - | 0.4 | ||||||||||||
|
Total other expense
|
2.1 | 1.2 | 1.9 | 2.5 | ||||||||||||
|
Net loss
|
(11.0 | )% | (3.0 | )% | (8.9 | )% | (15.0 | )% | ||||||||
|
(in thousands)
|
For the Fiscal Years Ended September 30,
|
|||||||||||||||||||
|
As of March 31, 2011
|
Total
|
2011
|
2012 to
2013
|
2014 to
2015
|
2016
and later
|
|||||||||||||||
|
Purchase obligations
|
$ | 27,762 | $ | 27,693 | $ | 61 | $ | 8 | $ | - | ||||||||||
|
Credit facility
|
13,710 | 13,710 | - | - | - | |||||||||||||||
|
Joint venture capital contribution
|
8,000 | 8,000 | - | - | ||||||||||||||||
|
Operating lease obligations
|
6,149 | 985 | 2,130 | 364 | 2,670 | |||||||||||||||
|
Capital lease obligation
|
8 | 3 | 5 | - | - | |||||||||||||||
|
Total contractual obligations
and commitments
|
$ | 55,629 | $ | 50,391 | $ | 2,196 | $ | 372 | $ | 2,670 | ||||||||||
|
a.
|
Evaluation of Disclosure Controls and Procedures
|
|
b.
|
Changes in Internal Control over Financial Reporting
|
|
c.
|
Completed Remediation Actions that Addressed Internal Control Weaknesses
|
|
d.
|
Limitations on the Effectiveness of Internal Control over Financial Reporting
|
|
Exhibit
Number
|
Description
|
|
10.1
|
Officer and Director Share Purchase Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 27, 2011)
|
|
Certificate of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
Certificate of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
Certificate of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
Certificate of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
EMCORE CORPORATION | |
|
|
|
|
|
Date:
May 5
, 2011
|
By: |
/s/ Hong Hou
|
|
Hong Q. Hou, Ph.D.
|
||
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
|
Date:
May 5
, 2011
|
By: |
/s/ Mark Weinswig
|
|
Mark Weinswig
|
||
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|